Loading…

Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort

Micro-Abstract We analyzed the National Cancer Data Base to assess adjuvant postprostatectomy radiation use and techniques for prostate cancer. Only 9.0% of men with adverse risk factors (pT3/4 or pT2 with positive margins) received adjuvant radiation. The use of radiation dose escalation rose over...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical genitourinary cancer 2017-02, Vol.15 (1), p.168-175
Main Authors:	Wong, Andrew T, Schwartz, David, Lee, Anna, Safdieh, Joseph, Osborn, Virginia, Schreiber, David
Format:	Article
Language:	English
Subjects:	Aged Androgen Antagonists - therapeutic use Combined Modality Therapy Hematology, Oncology and Palliative Medicine Humans Intensity-modulated radiotherapy Male Middle Aged Multimodality therapy Prostate cancer Prostatectomy Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Radical prostatectomy Radiotherapy Radiotherapy Dosage Radiotherapy, Adjuvant Radiotherapy, Intensity-Modulated - methods Treatment Outcome Urology
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3
cites	cdi_FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3
container_end_page	175
container_issue	1
container_start_page	168
container_title	Clinical genitourinary cancer
container_volume	15
creator	Wong, Andrew T Schwartz, David Lee, Anna Safdieh, Joseph Osborn, Virginia Schreiber, David
description	Micro-Abstract We analyzed the National Cancer Data Base to assess adjuvant postprostatectomy radiation use and techniques for prostate cancer. Only 9.0% of men with adverse risk factors (pT3/4 or pT2 with positive margins) received adjuvant radiation. The use of radiation dose escalation rose over time, corresponding to an increase in the use of intensity-modulated radiotherapy.
doi_str_mv	10.1016/j.clgc.2016.07.009
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859725429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1558767316302105</els_id><sourcerecordid>1859725429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3</originalsourceid><addsrcrecordid>eNp9kc2r1DAUxYsovg_9B1xIlm5ab9LmoyDCY1CfMDwHfa5DmqZvUttkTNIHg_-8KTO6cOEm9y7OOeT8blG8wlBhwOztWOnpQVck7xXwCqB9UlzithYlMEGe5p1SUXLG64viKsYRoKGYw_PignDaEArtZfFrp1IywUXkB7TzMR1CflQyOvn5iG76cXlULqGvqrc-7U1QhyO6N3rv7M_FRDT4gO68m01Sq81qtDsHoI1y2gRkHVJoq8KDQXdZ4J2a0MbvfUgvimeDmqJ5eZ7XxfePH-43t-X2y6fPm5ttqRuMUyka1TRA-sbwHno2UNZQrTnpRMeE4DWnWvSYtYS3gkDdiqEhNesoKN6xgXX1dfHmlJu7rZ9OcrZRm2lSzvglSixoy0km0mYpOUl1bhGDGeQh2FmFo8QgV-hylCt0uUKXwGWGnk2vz_lLN5v-r-UP5Sx4dxKY3PLRmiCjtibT6W3IoGXv7f_z3_9j15N1VqvphzmaOPolZKi5h4xEgvy2nn29OmY1EAy0_g2fGqjv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1859725429</pqid></control><display><type>article</type><title>Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Wong, Andrew T ; Schwartz, David ; Lee, Anna ; Safdieh, Joseph ; Osborn, Virginia ; Schreiber, David</creator><creatorcontrib>Wong, Andrew T ; Schwartz, David ; Lee, Anna ; Safdieh, Joseph ; Osborn, Virginia ; Schreiber, David</creatorcontrib><description>Micro-Abstract We analyzed the National Cancer Data Base to assess adjuvant postprostatectomy radiation use and techniques for prostate cancer. Only 9.0% of men with adverse risk factors (pT3/4 or pT2 with positive margins) received adjuvant radiation. The use of radiation dose escalation rose over time, corresponding to an increase in the use of intensity-modulated radiotherapy.</description><identifier>ISSN: 1558-7673</identifier><identifier>EISSN: 1938-0682</identifier><identifier>DOI: 10.1016/j.clgc.2016.07.009</identifier><identifier>PMID: 27542509</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Androgen Antagonists - therapeutic use ; Combined Modality Therapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Intensity-modulated radiotherapy ; Male ; Middle Aged ; Multimodality therapy ; Prostate cancer ; Prostatectomy ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - radiotherapy ; Prostatic Neoplasms - surgery ; Radical prostatectomy ; Radiotherapy ; Radiotherapy Dosage ; Radiotherapy, Adjuvant ; Radiotherapy, Intensity-Modulated - methods ; Treatment Outcome ; Urology</subject><ispartof>Clinical genitourinary cancer, 2017-02, Vol.15 (1), p.168-175</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3</citedby><cites>FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27542509$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, Andrew T</creatorcontrib><creatorcontrib>Schwartz, David</creatorcontrib><creatorcontrib>Lee, Anna</creatorcontrib><creatorcontrib>Safdieh, Joseph</creatorcontrib><creatorcontrib>Osborn, Virginia</creatorcontrib><creatorcontrib>Schreiber, David</creatorcontrib><title>Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort</title><title>Clinical genitourinary cancer</title><addtitle>Clin Genitourin Cancer</addtitle><description>Micro-Abstract We analyzed the National Cancer Data Base to assess adjuvant postprostatectomy radiation use and techniques for prostate cancer. Only 9.0% of men with adverse risk factors (pT3/4 or pT2 with positive margins) received adjuvant radiation. The use of radiation dose escalation rose over time, corresponding to an increase in the use of intensity-modulated radiotherapy.</description><subject>Aged</subject><subject>Androgen Antagonists - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Intensity-modulated radiotherapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multimodality therapy</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - radiotherapy</subject><subject>Prostatic Neoplasms - surgery</subject><subject>Radical prostatectomy</subject><subject>Radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Radiotherapy, Adjuvant</subject><subject>Radiotherapy, Intensity-Modulated - methods</subject><subject>Treatment Outcome</subject><subject>Urology</subject><issn>1558-7673</issn><issn>1938-0682</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc2r1DAUxYsovg_9B1xIlm5ab9LmoyDCY1CfMDwHfa5DmqZvUttkTNIHg_-8KTO6cOEm9y7OOeT8blG8wlBhwOztWOnpQVck7xXwCqB9UlzithYlMEGe5p1SUXLG64viKsYRoKGYw_PignDaEArtZfFrp1IywUXkB7TzMR1CflQyOvn5iG76cXlULqGvqrc-7U1QhyO6N3rv7M_FRDT4gO68m01Sq81qtDsHoI1y2gRkHVJoq8KDQXdZ4J2a0MbvfUgvimeDmqJ5eZ7XxfePH-43t-X2y6fPm5ttqRuMUyka1TRA-sbwHno2UNZQrTnpRMeE4DWnWvSYtYS3gkDdiqEhNesoKN6xgXX1dfHmlJu7rZ9OcrZRm2lSzvglSixoy0km0mYpOUl1bhGDGeQh2FmFo8QgV-hylCt0uUKXwGWGnk2vz_lLN5v-r-UP5Sx4dxKY3PLRmiCjtibT6W3IoGXv7f_z3_9j15N1VqvphzmaOPolZKi5h4xEgvy2nn29OmY1EAy0_g2fGqjv</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Wong, Andrew T</creator><creator>Schwartz, David</creator><creator>Lee, Anna</creator><creator>Safdieh, Joseph</creator><creator>Osborn, Virginia</creator><creator>Schreiber, David</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort</title><author>Wong, Andrew T ; Schwartz, David ; Lee, Anna ; Safdieh, Joseph ; Osborn, Virginia ; Schreiber, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Androgen Antagonists - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Intensity-modulated radiotherapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multimodality therapy</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - radiotherapy</topic><topic>Prostatic Neoplasms - surgery</topic><topic>Radical prostatectomy</topic><topic>Radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Radiotherapy, Adjuvant</topic><topic>Radiotherapy, Intensity-Modulated - methods</topic><topic>Treatment Outcome</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Andrew T</creatorcontrib><creatorcontrib>Schwartz, David</creatorcontrib><creatorcontrib>Lee, Anna</creatorcontrib><creatorcontrib>Safdieh, Joseph</creatorcontrib><creatorcontrib>Osborn, Virginia</creatorcontrib><creatorcontrib>Schreiber, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genitourinary cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Andrew T</au><au>Schwartz, David</au><au>Lee, Anna</au><au>Safdieh, Joseph</au><au>Osborn, Virginia</au><au>Schreiber, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort</atitle><jtitle>Clinical genitourinary cancer</jtitle><addtitle>Clin Genitourin Cancer</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>15</volume><issue>1</issue><spage>168</spage><epage>175</epage><pages>168-175</pages><issn>1558-7673</issn><eissn>1938-0682</eissn><abstract>Micro-Abstract We analyzed the National Cancer Data Base to assess adjuvant postprostatectomy radiation use and techniques for prostate cancer. Only 9.0% of men with adverse risk factors (pT3/4 or pT2 with positive margins) received adjuvant radiation. The use of radiation dose escalation rose over time, corresponding to an increase in the use of intensity-modulated radiotherapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27542509</pmid><doi>10.1016/j.clgc.2016.07.009</doi><tpages>8</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1558-7673
ispartof	Clinical genitourinary cancer, 2017-02, Vol.15 (1), p.168-175
issn	1558-7673 1938-0682
language	eng
recordid	cdi_proquest_miscellaneous_1859725429
source	ScienceDirect Freedom Collection 2022-2024
subjects	Aged Androgen Antagonists - therapeutic use Combined Modality Therapy Hematology, Oncology and Palliative Medicine Humans Intensity-modulated radiotherapy Male Middle Aged Multimodality therapy Prostate cancer Prostatectomy Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Prostatic Neoplasms - surgery Radical prostatectomy Radiotherapy Radiotherapy Dosage Radiotherapy, Adjuvant Radiotherapy, Intensity-Modulated - methods Treatment Outcome Urology
title	Patterns of Postprostatectomy Adjuvant Radiotherapy Techniques for Nonmetastatic Prostate Cancer in a Large National Cohort
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T01%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Patterns%20of%20Postprostatectomy%20Adjuvant%20Radiotherapy%20Techniques%20for%20Nonmetastatic%20Prostate%20Cancer%20in%20a%20Large%20National%20Cohort&rft.jtitle=Clinical%20genitourinary%20cancer&rft.au=Wong,%20Andrew%20T&rft.date=2017-02-01&rft.volume=15&rft.issue=1&rft.spage=168&rft.epage=175&rft.pages=168-175&rft.issn=1558-7673&rft.eissn=1938-0682&rft_id=info:doi/10.1016/j.clgc.2016.07.009&rft_dat=%3Cproquest_cross%3E1859725429%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-84a4402d4e7d0d6f5645cc72b8b6887375c8d169279820398f4236b50a7b6f6b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1859725429&rft_id=info:pmid/27542509&rfr_iscdi=true